Management of the Highly HLA‐ Sensitized Patient. A Novel Role for Intravenous Gammaglobulin

This publication has 8 references indexed in Scilit:

• Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
  New England Journal of Medicine, 2001
• REVERSAL OF STEROID- AND ANTI-LYMPHOCYTE ANTIBODY- RESISTANT REJECTION USING INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN RENAL TRANSPLANT RECIPIENTS
  Transplantation, 2001
• A RANDOMIZED AND PROSPECTIVE STUDY COMPARING TREATMENT WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN WITH MONOCLONAL ANTIBODIES FOR RESCUE OF KIDNEY GRAFTS WITH STEROID-RESISTANT REJECTION
  Transplantation, 2001
• PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS
  Transplantation, 2000
• POSTTRANSPLANT THERAPY USING HIGH-DOSE HUMAN IMMUNOGLOBULIN (INTRAVENOUS GAMMAGLOBULIN) TO CONTROL ACUTE HUMORAL REJECTION IN RENAL AND CARDIAC ALLOGRAFT RECIPIENTS AND POTENTIAL MECHANISM OF ACTION1
  Transplantation, 1998
• UTILIZATION OF INTRAVENOUS IMMUNOGLOBULIN TO AMELIORATE ALLOANTIBODIES IN A HIGHLY SENSITIZED PATIENT WITH A CARDIAC ASSIST DEVICE AWAITING HEART TRANSPLANTATION
  Transplantation, 1996
• INTRAVENOUS IMMUNOGLOBULIN SUPPRESSION OF HLA ALLOANTIBODY IN HIGHLY SENSITIZED TRANSPLANT CANDIDATES AND TRANSPLANTATION WITH A HISTOINCOMPATIBLE ORGAN
  Transplantation, 1994
• SUPPRESSION OF HLA-SPECIFIC ALLOANTIBODIES BY HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIg)
  Transplantation, 1993